BioSpace News Archive

Drug Development

Avelas Biosciences Completes Period 1 Patient Enrollment in Phase II Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Period 1 was designed to enroll approximately 30 patients to evaluate optimal conditions to achieve differences in fluorescent signals between malignant and nonmalignant tissues.

January 5, 2018
·
2 min read
Pharm Country

New Jersey’s Leading Pharma, LLC Scores $40M

The transaction was led by Signet Healthcare Partners in addition to Crestline Investors with other investors comprised of Cane Investment Partners and existing Leading Pharma members.

January 5, 2018
·
4 min read
Deals

Fuse Medical, Inc. Completes Acquisition of CPM Medical Consultants, LLC

The effective date of closing was December 31, 2017.

January 5, 2018
·
2 min read
Helix Biopharma Corp. to Present at the Biotech Showcase Conference

Helix Biopharma today announced it has been selected to present at the Biotech Showcase Conference on Monday, January 8, 2018 at 4:30pm (PT) at Hilton San Francisco Union Square.

January 5, 2018
·
6 min read
Business

OrthoPediatrics Corp. Announces Preliminary Revenue for Fourth Quarter and Full Year 2017

OrthoPediatrics’ preliminary unaudited full year 2017 revenue is expected to be in the range of $45.4 million to $45.6 million, representing annual growth of 22%.

January 5, 2018
·
1 min read
Business

Advanced Bifurcation Systems Announces Scott King Joins as Chief of Compliance Ahead of FDA Application

ABS Scott King has joined the leadership team as VP of Regulatory Affairs.

January 5, 2018
·
2 min read
GeneNews Announces Letter to Shareholders From CEO

GeneNews released a Letter to Shareholders updating current activities and outlining its corporate strategy for 2018.

January 5, 2018
·
4 min read
Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders

Veritas Pharma has experienced tremendous activity over the past year.

January 5, 2018
·
10 min read
Policy

Anaheim Clinical Trials Passes 6th FDA Inspection in Last 3 Years for High Enrollment With No Violations

ACT recently completed its 6th FDA inspection in the last three consecutive years for high enrollment with no violations.

January 5, 2018
·
1 min read
Business

miRagen Therapeutics Expands Board of Directors With Appointment of Arlene Morris

Her appointment increases miRagen’s Board from seven directors to eight directors.

January 5, 2018
·
6 min read